MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 29.03.2023
Land |
 Vereinigte Staaten |
IPO-Jahr |
2018 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
74.7 M |
Marktkapitalisierung |
$ 2.37 B |
EBITDA (LTM) |
$ -115 M |
P/E (LTM) |
- |
P/S (LTM) |
1175.58 |
EPS (LTM) |
-1.58 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Regeneron Pharmaceuticals
REGN
|
$ 742.1 | -1.93 % | $ 77.6 B | Nasdaq Global Select Market,SPB | USA |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
AbbVie
ABBV
|
$ 211.9 | 0.37 % | $ 375 B | NYSE,SPB | USA |
 |
Replimune Group
REPL
|
$ 7.26 | -3.71 % | $ 585 M | Nasdaq Global Select Market | USA |
 |
AbCellera Biologics
ABCL
|
$ 3.28 | -2.24 % | $ 980 M | Nasdaq Global Select Market |  Canada |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market |  France |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Rigel Pharmaceuticals
RIGL
|
$ 26.28 | -0.34 % | $ 473 M | Nasdaq Global Select Market | USA |
 |
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | USA |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Arena Pharmaceuticals
ARNA
|
- | -6.81 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Avenue Therapeutics
ATXI
|
- | -52.27 % | $ 4.45 M | Nasdaq Global Select Market | USA |
 |
Avidity Biosciences
RNA
|
$ 13.07 | -0.23 % | $ 1.8 B | Nasdaq Global Select Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
bluebird bio
BLUE
|
- | - | $ 546 M | Nasdaq Global Select Market,SPB | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market | Canada |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 77.56 | -5.31 % | $ 5.04 B | Nasdaq Global Market,SPB | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Avid Bioservices
CDMO
|
- | - | $ 789 M | Nasdaq Capital Market | USA |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 12.27 | -12.11 % | $ 1.86 B | Nasdaq Global Select Market,SPB | USA |
 |
BeiGene, Ltd.
BGNE
|
- | 0.49 % | $ 251 B | Nasdaq Global Select Market |  Cayman-islands |
 |
SIGA Technologies
SIGA
|
$ 5.36 | 7.96 % | $ 383 M | Nasdaq Global Select Market | USA |
 |
Silence Therapeutics plc
SLN
|
$ 4.92 | -7.34 % | $ 622 M | Nasdaq Global Select Market | Britain |
 |
SELLAS Life Sciences Group
SLS
|
$ 4.47 | -9.69 % | $ 487 M | Nasdaq Capital Market | USA |
 |
BioDelivery Sciences International
BDSI
|
- | -4.8 % | $ 255 M | Nasdaq Global Select Market | USA |
 |
Cara Therapeutics
CARA
|
- | -3.03 % | $ 260 M | Nasdaq Global Market,SPB | USA |
 |
ChemoCentryx
CCXI
|
- | - | $ 3.74 B | Nasdaq Global Select Market,SPB | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
$ 1.08 | -1.38 % | $ 22.2 M | Nasdaq Capital Market | Israel |
 |
Enochian Biosciences
ENOB
|
- | - | $ 40.5 M | Nasdaq Capital Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Summit Therapeutics
SMMT
|
$ 16.59 | -3.88 % | $ 12.4 B | Nasdaq Global Select Market | Britain |
 |
Spruce Biosciences
SPRB
|
$ 62.07 | -10.19 % | $ 47.6 M | Nasdaq Global Select Market | USA |